2012
Small-molecule-induced Rho-inhibition: NSAIDs after spinal cord injury
Kopp MA, Liebscher T, Niedeggen A, Laufer S, Brommer B, Jungehulsing GJ, Strittmatter SM, Dirnagl U, Schwab JM. Small-molecule-induced Rho-inhibition: NSAIDs after spinal cord injury. Cell And Tissue Research 2012, 349: 119-132. PMID: 22350947, PMCID: PMC3744771, DOI: 10.1007/s00441-012-1334-7.Peer-Reviewed Original ResearchConceptsSpinal cord injuryCentral nervous systemAxonal plasticityCord injuryAcute spinal cord injuryExperimental spinal cord injuryNon-steroid anti-inflammatory drugsRelevant SCI modelGrowth-inhibitory environmentCNS injury modelsAnti-inflammatory drugsOligodendrocyte myelin glycoproteinRhoA inhibitionRepulsive guidance moleculeMotor recoveryAxonal sproutingPreclinical evidenceFunctional recoveryLocomotor recoverySCI modelChondroitin sulfate proteoglycanCNS injuryNeurofunctional outcomeGrowth cone collapsePossible clinical translation
2005
NG2: a component of the glial scar that inhibits axon growth
Tan A, Zhang W, Levine J. NG2: a component of the glial scar that inhibits axon growth. Journal Of Anatomy 2005, 207: 717-725. PMID: 16367799, PMCID: PMC1571583, DOI: 10.1111/j.1469-7580.2005.00452.x.Peer-Reviewed Original ResearchConceptsOligodendrocyte precursor cellsGlial scarNG2-expressing oligodendrocyte precursor cellsGrowth-inhibitory environmentSpinal cord resultsCord resultsInhibit axonal growthCNS injuryInjury siteSurface of oligodendrocyte precursor cellsPrecursor cellsAxonal regenerationAxonal regrowthChondroitin sulphate proteoglycansInjury to brainNG2ScarsInjuryAxonal growth
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply